FBXW7 is involved in Aurora B degradation

References

• Carmena M, Earnshaw WC. The cellular geography of aurora kinases. Nat Rev Mol Cell Biol 2003; 4:842 - 54; http://dx.doi.org/10.1038/nrm1245; PMID: 14625535
   PubMed Web of Science ®Google Scholar
• Ruchaud S, Carmena M, Earnshaw WC. Chromosomal passengers: conducting cell division. Nat Rev Mol Cell Biol 2007; 8:798 - 812; http://dx.doi.org/10.1038/nrm2257; PMID: 17848966
   PubMed Web of Science ®Google Scholar
• Lindqvist A, Rodríguez-Bravo V, Medema RH. The decision to enter mitosis: feedback and redundancy in the mitotic entry network. J Cell Biol 2009; 185:193 - 202; http://dx.doi.org/10.1083/jcb.200812045; PMID: 19364923
   PubMed Web of Science ®Google Scholar
• Fu J, Bian M, Jiang Q, Zhang C. Roles of Aurora kinases in mitosis and tumorigenesis. Mol Cancer Res 2007; 5:1 - 10; http://dx.doi.org/10.1158/1541-7786.MCR-06-0208; PMID: 17259342
   PubMed Web of Science ®Google Scholar
• Ducat D, Zheng Y. Aurora kinases in spindle assembly and chromosome segregation. Exp Cell Res 2004; 301:60 - 7; http://dx.doi.org/10.1016/j.yexcr.2004.08.016; PMID: 15501446
   PubMed Web of Science ®Google Scholar
• Katayama H, Brinkley WR, Sen S. The Aurora kinases: role in cell transformation and tumorigenesis. Cancer Metastasis Rev 2003; 22:451 - 64; http://dx.doi.org/10.1023/A:1023789416385; PMID: 12884918
   PubMedGoogle Scholar
• Lens SM, Voest EE, Medema RH. Shared and separate functions of polo-like kinases and aurora kinases in cancer. Nat Rev Cancer 2010; 10:825 - 41; http://dx.doi.org/10.1038/nrc2964; PMID: 21102634
   PubMed Web of Science ®Google Scholar
• Sampath SC, Ohi R, Leismann O, Salic A, Pozniakovski A, Funabiki H. The chromosomal passenger complex is required for chromatin-induced microtubule stabilization and spindle assembly. Cell 2004; 118:187 - 202; http://dx.doi.org/10.1016/j.cell.2004.06.026; PMID: 15260989
   PubMed Web of Science ®Google Scholar
• Slattery SD, Moore RV, Brinkley BR, Hall RM. Aurora-C and Aurora-B share phosphorylation and regulation of CENP-A and Borealin during mitosis. Cell Cycle 2008; 7:787 - 95; http://dx.doi.org/10.4161/cc.7.6.5563; PMID: 18239465
   PubMed Web of Science ®Google Scholar
• Hoeller D, Hecker CM, Dikic I. Ubiquitin and ubiquitin-like proteins in cancer pathogenesis. Nat Rev Cancer 2006; 6:776 - 88; http://dx.doi.org/10.1038/nrc1994; PMID: 16990855
   PubMed Web of Science ®Google Scholar
• Onoyama I, Nakayama KI. Fbxw7 in cell cycle exit and stem cell maintenance: insight from gene-targeted mice. Cell Cycle 2008; 7:3307 - 13; http://dx.doi.org/10.4161/cc.7.21.6931; PMID: 18948752
   PubMed Web of Science ®Google Scholar
• Malyukova A, Dohda T, von der Lehr N, Akhoondi S, Corcoran M, Heyman M, et al. The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling. Cancer Res 2007; 67:5611 - 6; http://dx.doi.org/10.1158/0008-5472.CAN-06-4381; PMID: 17575125
   PubMed Web of Science ®Google Scholar
• Akhoondi S, Sun D, von der Lehr N, Apostolidou S, Klotz K, Maljukova A, et al. FBXW7/hCDC4 is a general tumor suppressor in human cancer. Cancer Res 2007; 67:9006 - 12; http://dx.doi.org/10.1158/0008-5472.CAN-07-1320; PMID: 17909001
   PubMed Web of Science ®Google Scholar
• Welcker M, Clurman BE. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer 2008; 8:83 - 93; http://dx.doi.org/10.1038/nrc2290; PMID: 18094723
   PubMed Web of Science ®Google Scholar
• Minella AC, Clurman BE. Mechanisms of tumor suppression by the SCF(Fbw7). Cell Cycle 2005; 4:1356 - 9; http://dx.doi.org/10.4161/cc.4.10.2058; PMID: 16131838
   PubMed Web of Science ®Google Scholar
• Mao JH, Perez-Losada J, Wu D, Delrosario R, Tsunematsu R, Nakayama KI, et al. Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene. Nature 2004; 432:775 - 9; http://dx.doi.org/10.1038/nature03155; PMID: 15592418
   PubMed Web of Science ®Google Scholar
• Spruck CH, Strohmaier H, Sangfelt O, Müller HM, Hubalek M, Müller-Holzner E, et al. hCDC4 gene mutations in endometrial cancer. Cancer Res 2002; 62:4535 - 9; PMID: 12183400
   PubMed Web of Science ®Google Scholar
• Rajagopalan H, Jallepalli PV, Rago C, Velculescu VE, Kinzler KW, Vogelstein B, et al. Inactivation of hCDC4 can cause chromosomal instability. Nature 2004; 428:77 - 81; http://dx.doi.org/10.1038/nature02313; PMID: 14999283
   PubMed Web of Science ®Google Scholar
• Knuutila S, Aalto Y, Autio K, Björkqvist AM, El-Rifai W, Hemmer S, et al. DNA copy number losses in human neoplasms. Am J Pathol 1999; 155:683 - 94; http://dx.doi.org/10.1016/S0002-9440(10)65166-8; PMID: 10487825
   PubMed Web of Science ®Google Scholar
• Grim JE, Gustafson MP, Hirata RK, Hagar AC, Swanger J, Welcker M, et al. Isoform- and cell cycle-dependent substrate degradation by the Fbw7 ubiquitin ligase. J Cell Biol 2008; 181:913 - 20; http://dx.doi.org/10.1083/jcb.200802076; PMID: 18559665
   PubMed Web of Science ®Google Scholar
• Gully CP, Velazquez-Torres G, Shin JH, Fuentes-Mattei E, Wang E, Carlock C, et al. Aurora B kinase phosphorylates and instigates degradation of p53. Proc Natl Acad Sci USA 2012; 109:E1513 - 22; http://dx.doi.org/10.1073/pnas.1110287109; PMID: 22611192
   PubMed Web of Science ®Google Scholar
• Ye X, Nalepa G, Welcker M, Kessler BM, Spooner E, Qin J, et al. Recognition of phosphodegron motifs in human cyclin E by the SCF(Fbw7) ubiquitin ligase. J Biol Chem 2004; 279:50110 - 9; http://dx.doi.org/10.1074/jbc.M409226200; PMID: 15364936
   PubMed Web of Science ®Google Scholar
• Thompson BJ, Buonamici S, Sulis ML, Palomero T, Vilimas T, Basso G, et al. The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia. J Exp Med 2007; 204:1825 - 35; http://dx.doi.org/10.1084/jem.20070872; PMID: 17646408
   PubMed Web of Science ®Google Scholar
• Gully CP, Zhang F, Chen J, Yeung JA, Velazquez-Torres G, Wang E, et al. Antineoplastic effects of an Aurora B kinase inhibitor in breast cancer. Mol Cancer 2010; 9:42; http://dx.doi.org/10.1186/1476-4598-9-42; PMID: 20175926
   PubMed Web of Science ®Google Scholar
• Knauer SK, Mann W, Stauber RH. Survivin’s dual role: an export’s view. Cell Cycle 2007; 6:518 - 21; http://dx.doi.org/10.4161/cc.6.5.3902; PMID: 17361097
   PubMed Web of Science ®Google Scholar
• Lens SM, Rodriguez JA, Vader G, Span SW, Giaccone G, Medema RH. Uncoupling the central spindle-associated function of the chromosomal passenger complex from its role at centromeres. Mol Biol Cell 2006; 17:1897 - 909; http://dx.doi.org/10.1091/mbc.E05-08-0727; PMID: 16436504
   PubMed Web of Science ®Google Scholar
• Jelluma N, Brenkman AB, van den Broek NJ, Cruijsen CW, van Osch MH, Lens SM, et al. Mps1 phosphorylates Borealin to control Aurora B activity and chromosome alignment. Cell 2008; 132:233 - 46; http://dx.doi.org/10.1016/j.cell.2007.11.046; PMID: 18243099
   PubMed Web of Science ®Google Scholar
• Ricke RM, van Deursen JM. Aurora B hyperactivation by Bub1 overexpression promotes chromosome missegregation. Cell Cycle 2011; 10:3645 - 51; http://dx.doi.org/10.4161/cc.10.21.18156; PMID: 22033440
   PubMed Web of Science ®Google Scholar
• Nguyen HG, Chinnappan D, Urano T, Ravid K. Mechanism of Aurora-B degradation and its dependency on intact KEN and A-boxes: identification of an aneuploidy-promoting property. Mol Cell Biol 2005; 25:4977 - 92; http://dx.doi.org/10.1128/MCB.25.12.4977-4992.2005; PMID: 15923616
   PubMed Web of Science ®Google Scholar
• Stewart S, Fang G. Destruction box-dependent degradation of aurora B is mediated by the anaphase-promoting complex/cyclosome and Cdh1. Cancer Res 2005; 65:8730 - 5; http://dx.doi.org/10.1158/0008-5472.CAN-05-1500; PMID: 16204042
   PubMed Web of Science ®Google Scholar
• Sumara I, Quadroni M, Frei C, Olma MH, Sumara G, Ricci R, et al. A Cul3-based E3 ligase removes Aurora B from mitotic chromosomes, regulating mitotic progression and completion of cytokinesis in human cells. Dev Cell 2007; 12:887 - 900; http://dx.doi.org/10.1016/j.devcel.2007.03.019; PMID: 17543862
   PubMed Web of Science ®Google Scholar
• Yeung SC, Gully C, Lee MH. Aurora-B kinase inhibitors for cancer chemotherapy. Mini Rev Med Chem 2008; 8:1514 - 25; http://dx.doi.org/10.2174/138955708786786480; PMID: 19075809
   PubMed Web of Science ®Google Scholar
• Keen N, Taylor S. Aurora-kinase inhibitors as anticancer agents. Nat Rev Cancer 2004; 4:927 - 36; http://dx.doi.org/10.1038/nrc1502; PMID: 15573114
   PubMed Web of Science ®Google Scholar
• Sanhaji M, Friel CT, Wordeman L, Louwen F, Yuan JP. Mitotic centromere-associated kinesin (MCAK): a potential cancer drug target. Oncotarget 2011; 2:935 - 47; PMID: 22249213
   PubMed Web of Science ®Google Scholar
• Wang Z, Inuzuka H, Zhong J, Wan L, Fukushima H, Sarkar FH, et al. Tumor suppressor functions of FBW7 in cancer development and progression. FEBS Lett 2012; 586:1409 - 18; http://dx.doi.org/10.1016/j.febslet.2012.03.017; PMID: 22673505
   PubMed Web of Science ®Google Scholar
• Yada M, Hatakeyama S, Kamura T, Nishiyama M, Tsunematsu R, Imaki H, et al. Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7. EMBO J 2004; 23:2116 - 25; http://dx.doi.org/10.1038/sj.emboj.7600217; PMID: 15103331
   PubMed Web of Science ®Google Scholar
• Orlicky S, Tang X, Willems A, Tyers M, Sicheri F. Structural basis for phosphodependent substrate selection and orientation by the SCFCdc4 ubiquitin ligase. Cell 2003; 112:243 - 56; http://dx.doi.org/10.1016/S0092-8674(03)00034-5; PMID: 12553912
   PubMed Web of Science ®Google Scholar
• Jin J, Ang XL, Shirogane T, Wade Harper J. Identification of substrates for F-box proteins. Methods Enzymol 2005; 399:287 - 309; http://dx.doi.org/10.1016/S0076-6879(05)99020-4; PMID: 16338364
   PubMed Web of Science ®Google Scholar
• Wu CC, Yang TY, Yu CT, Phan L, Ivan C, Sood AK, et al. p53 negatively regulates Aurora A via both transcriptional and posttranslational regulation. Cell Cycle 2012; 11:3433 - 42; PMID: 22894933
   PubMed Web of Science ®Google Scholar
• Chiang CM. p53-Aurora A mitotic feedback loop regulates cell cycle progression and genomic stability. Cell Cycle 2012; 11; In press PMID: 22982999
   PubMed Web of Science ®Google Scholar
• Wu LM, Ma CA, Jain A. When Aurora B met p53: newly revealed regulatory phosphorylation in an old protein. Cell Cycle 2011; 10:171 - 2; http://dx.doi.org/10.4161/cc.10.2.14349; PMID: 21212738
   PubMed Web of Science ®Google Scholar
• Laronga C, Yang HY, Neal C, Lee MH. Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression. J Biol Chem 2000; 275:23106 - 12; http://dx.doi.org/10.1074/jbc.M905616199; PMID: 10767298
   PubMed Web of Science ®Google Scholar
• Yang HY, Wen YY, Chen CH, Lozano G, Lee MH. 14-3-3 sigma positively regulates p53 and suppresses tumor growth. Mol Cell Biol 2003; 23:7096 - 107; http://dx.doi.org/10.1128/MCB.23.20.7096-7107.2003; PMID: 14517281
   PubMed Web of Science ®Google Scholar
• Yang HY, Wen YY, Lin YI, Pham L, Su CH, Yang H, et al. Roles for negative cell regulator 14-3-3sigma in control of MDM2 activities. Oncogene 2007; 26:7355 - 62; http://dx.doi.org/10.1038/sj.onc.1210540; PMID: 17546054
   PubMed Web of Science ®Google Scholar
• Yang H, Zhao R, Lee MH. 14-3-3sigma, a p53 regulator, suppresses tumor growth of nasopharyngeal carcinoma. Mol Cancer Ther 2006; 5:253 - 60; http://dx.doi.org/10.1158/1535-7163.MCT-05-0395; PMID: 16505098
   PubMed Web of Science ®Google Scholar